larotrectinib,entrectinib
bayer,roche
['entrectinib', 'larotrectinib']
despite the lack of late-breaking oral presentations in #ntrk gene fusion during #asco22, , maciej jerzy krzakowski &amp; xiao-li wei present updated results for #entrectinib #larotrectinib the 2 approved trk inhibitors and preliminary data with a next gen: icp-723.
#meded 
group of independent and international experts in the field of medical #oncology and #pathology related to #NTRK gene fusions. Part of https://t.co/83nVzqjBga